All In MedTech

Device Trial Radar · NCT05329129

OssDsign® Spine Registry Study ("Propel")

PROSPECTIVE OBSERVATIONAL SPINE FUSION REGISTRY FOR OssDsign® BONE GRAFT SUBSTITUTES IN REAL WORLD CLINICAL PRACTICE

Last checked: Nov 19, 2026Latest source record: Oct 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

450

Planned (sponsor's estimate)

Start

Mar 23, 2022

Primary completion

Mar 23, 2030

Study completion Apr 1, 2030

Sponsor

Lead sponsor
OssDsignNot on our public-company list
Sponsor type
Industry
First posted
Apr 14, 2022

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 21 years

Summary

As written by the sponsor on the registry.

The purpose of this multi-center, prospective, observational registry is to gather information on the clinical outcomes and real-world use of commercially available bone graft substitutes manufactured by OssDsign® AB, in patients who require spine fusion.

Conditions

  • Degenerative Disc Disease
  • Spinal Stenosis

Interventions

  • OssDsign® CatalystDevice

    An osteoconductive, resorbable, porous, 100 % nano synthetic calcium phosphate bone void filler

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of bone fusionTime frame: 12 months ± 60 days post-operative examination

Locations

16 sites in 1 country. Site status is shown where the registry gives one.

  • Community Health Partners Neuroscience

    Fresno, California · Recruiting

  • Memorial Orthopaedic Surgical Group

    Long Beach, California · Recruiting

  • San Diego Neurosurgery

    San Diego, California · Terminated

13 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.